[Skip to Navigation]
Sign In
Views 779
Citations 0
Comment & Response
July 1, 2021

Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants—Caution Needed

Author Affiliations
  • 1Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  • 2Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
  • 3Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia
  • 4Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
  • 5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
JAMA Oncol. 2021;7(9):1401. doi:10.1001/jamaoncol.2021.2037

To the Editor The study by Choi et al1 evaluated risk-reducing salpingo-oophorectomy (RRSO) as a breast cancer prevention strategy in women with pathogenic germline BRCA1 and BRCA2 variants. This issue is of critical importance to women with these variants and to the clinicians who care for them. Unlike some other contemporary studies of this issue,2-5 Choi et al1 reported an association of RRSO with a reduction in breast cancer risk in women carrying BRCA1 and BRCA2 pathogenic gene variants. However, the study appears to have several methodological limitations, which means the results should be interpreted with caution.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words